Peregrine Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.18M	Buy	+96,306	New	+$4.08M	0.12%	238
2024 Q1	–	Sell	-344,532	Closed	-$10.6M	–	324
2023 Q4	$10.6M	Sell	344,532 -114,658	-25%	-$2.87M	0.32%	64
2023 Q3	$10.3M	Sell	459,190 -19,636	-4%	-$448K	0.31%	92
2023 Q2	$10.3M	Sell	478,826 -19,822	-4%	-$450K	0.28%	118
2023 Q1	$12M	Sell	498,648 -42,744	-8%	-$1.13M	0.35%	81
2022 Q4	$12.6M	Sell	541,392 -5,889	-1%	-$119K	0.39%	65
2022 Q3	$8.77M	Sell	547,281 -1,477	-0.3%	-$26K	0.28%	158
2022 Q2	$9.72M	Sell	548,758 -7,900	-1%	-$133K	0.29%	143
2022 Q1	$11.3M	Sell	556,658 -19,241	-3%	-$364K	0.27%	146
2021 Q4	$10.8M	Sell	575,899 -106,165	-16%	-$2.07M	0.22%	182
2021 Q3	$13.5M	Buy	+682,064	New	+$14.7M	0.28%	130